CARD ID | 257 | |
Type of strain | Transgenic. | |
Strain name | C57BL/6-Tg(TCR-OT-II.2)Cbn | |
Internal Code | C57BL/6-TgN(TCR-OT-?)cbn, OT-II, C57BL/6-TgN(TCR-OT-?)Cbn | |
Submitter | Shigeo Koyasu | |
Submitter affiliation or code | RIKEN | |
Stock Type | ||
Material Transfer Conditions |
Consent to us
|
|
Production method | From other organizations | |
Origin (In-house) | Organization | |
Organization code | ||
Developer | ||
Origin (From other organizations) | Organization | Walter Eliza Hall Institute |
Organization code | ||
Developer | William R. Heath | |
Year introduced | 2001 / 4 | |
Introduced Generation | N? | |
Remarks |
Gene symbol | ? TCRAV2 TCRBV5 ? |
Gene name | V alpha 2J alpha ? V beta 5D beta ? J beta ? |
Allele symbol | |
Allele name | |
MGI | |
Chromosome | |
Gene classification | Gene to express(transgenic) |
Method | |
OMIM |
primerA | PCR primers used to amplify the transgenic TCR α-chain are:, Vα2-5' 5'-AAA GGG AGA AAA AGC TCT CC-3', Cαb 5'-ACA CAG CAG GTT CTG GGT TC-3', which amplify a 160 bp fragment(from Casanova et al., 1991, J.Exp. Med. 174:1371) |
primerB | As an internal control, primers to insulin can also used. These are:, MINSIXHOF-5' 5'-CGA GCT CGA GCC TGC CTA TCT TTC AGG TC-3', MINSBAMR-5' 5'-CGG GAT CCT AGT TGC AGT AGT TCT CCA G-3', which amplify a 380 bp fragment of the insulin gene. |
Author | MEGAN J BARNDEN, JAN ALLISON, WILLIAM R HEATH and FRANCIS R CARBONE |
Title | Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements |
Journal | Immunology and Cell Biology |
Volume | 76 |
Page | 34-40 |
Year | 1998 |
PMID | 9553774 |
Disease name, Applicable field | Immunology |